ID: ALA5316200

Max Phase: Preclinical

Molecular Formula: C7H12O

Molecular Weight: 112.17

Associated Items:

Representations

Canonical SMILES:  O[C@H]1C[C@H]2CC[C@@H]1C2

Standard InChI:  InChI=1S/C7H12O/c8-7-4-5-1-2-6(7)3-5/h5-8H,1-4H2/t5-,6+,7-/m0/s1

Standard InChI Key:  ZQTYQMYDIHMKQB-XVMARJQXSA-N

Associated Targets(Human)

UDP-glucuronosyltransferase 1A4 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 112.17Molecular Weight (Monoisotopic): 112.0888AlogP: 1.17#Rotatable Bonds: 0
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.02CX LogD: 1.02
Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.50Np Likeness Score: 1.53

References

1. Tukey RH, Strassburg CP..  (2000)  Human UDP-glucuronosyltransferases: metabolism, expression, and disease.,  40  (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581]

Source